Veradigm | MDRX - Loan Capital


Veradigm reported $200.4M in Loan Capital for its fiscal quarter ending in December of 2022.





Loan Capital Change Date
Alcidion AUD 318K 376K Dec/2025
Ambu A/S DKK 17M 3M Mar/2026
Amplifon EUR 1.05B 442.1M Jun/2026
Cardinal Health USD 7B 1.24B Jun/2026
Centene USD 16.03B 278M Jun/2026
Charles River Laboratories USD 2.62B 43.15M Jun/2026
Cigna USD 29.09B 285M Jun/2026
Coloplast 21.39B 1.34B Dec/2025
Convatec Group USD 1.18B 211.4M Dec/2024
CVS Health USD 59.45B 1.08B Jun/2026
Diasorin EUR 472.05M 199.95M Jun/2025
Elevance Health USD 30.67B 99M Jun/2026
General Electric Aerospace USD 17.16B 1.02B Jun/2026
Gulf Medical Proj AED 2.32M 775K Mar/2026
Humana USD 11.98B 295M Jun/2026
IQVIA Holdings USD 13.7B 284M Jun/2026
Laboratory Of America USD 5.92B 23.3M Jun/2026
Maximus USD 1.57B 93.52M Jun/2026
McKesson USD 8.43B 3.17B Jun/2026
Med Life RON 1.48B 231.92M Mar/2026
Molina Healthcare USD 3.95B 186M Jun/2026
Omnicell USD 168.2M 304K Jun/2026
Oriola-kd EUR 37.6M 700K Mar/2026
Owens Minor USD 1.8B 35.38M Dec/2025
Quest Diagnostics USD 5.63B 477M Jun/2026
Rede D'or Sao Luiz BRL 51.97B 4.95B Jun/2026
Siemens Healthineers EUR 11.49B 69M Jun/2026
Sonova Holding CHF 1.39B 209.8M Jun/2025
Supermax Corporation Bhd MYR 16.59M 439K Mar/2026
UnitedHealth USD 69.5B 1.94B Jun/2026
Veradigm USD 200.4M 69K Dec/2022
Xerox USD 3.48B 785M Jun/2025